Elstar Therapeutics Revenue and Competitors

Claim your profile

Boston, MA USA

Location

$39M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Elstar Therapeutics's estimated annual revenue is currently $9.8M per year.(i)
  • Elstar Therapeutics received $39.0M in venture funding in January 2018.
  • 0
  • Elstar Therapeutics's total funding is $39M.

Employee Data

    00
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-94%N/AN/A
#2
$2.6M17N/AN/AN/A
#3
$6M39-20%$176.5MN/A
#4
$4.5M29N/AN/AN/A
#5
$2.6M17N/AN/AN/A
#6
N/A145-21%$39.5MN/A
#7
N/A0N/A$9.5MN/A
#8
$15.9M159-39%$135MN/A
#9
$1.7M1157%$20.9MN/A
#10
$2.8M1850%$28.9MN/A

Elstar Therapeutics brings a powerful new approach to generating multi-functional therapeutics with the potential to fulfill the promise of precision cancer immunotherapy and chart new directions in fighting immunological diseases. Armed with a platform that enables rapid production of multi-functional molecules effective in modulating a broad range of immunological processes, Elstar's goal is to develop new medicines for life-threatening cancers and serious inflammatory diseases. Our Universal Targeted Immunotherapy (UniTI) platform uniquely positions Elstar to overcome barriers that have previously blocked many promising immunotherapeutic approaches. Elstar Therapeutics was founded by the veteran protein and antibody engineer Andreas Loew together with Apple Tree Partners (www.appletreepartners.com), a healthcare-focused venture capital firm based in New York City.

keywords:N/A

$39M

Total Funding

N/A

Number of Employees

$9.8M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Elstar Therapeutics News

09/06/2019 - Randy Schatzman jumps to the helm of another start-up; Novo ...

Prior to hopping on board to Atlas, Godec was the senior associate at Apple Tree Partners, involved in building Elstar Therapeutics, ...

01/03/2018 - Elstar Therapeutics Closes $39M Series A Financing to ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Elstar Therapeutics, a company fulfilling the promise of precision cancer immunotherapy through a ...

07/31/2018 - Elstar Therapeutics Appoints Leaders in Drug Research and ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Elstar Therapeutics, a company fulfilling the promise of precision cancer immunotherapy through a ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$64.9M0N/A$751.3M
#2
$12.9M0N/A$163M
#3
$4.8M0N/AN/A
#4
$49.2M0N/A$132.9M
#5
$33.3M0N/A$15M

Elstar Therapeutics Funding

DateAmountRoundLead InvestorsReference
2018-01-04$39.0MAApple Tree PartnersArticle